Tarsus Reconciled Depreciation from 2010 to 2025

TARS Stock  USD 43.91  1.35  3.17%   
Tarsus Pharmaceuticals Reconciled Depreciation yearly trend continues to be comparatively stable with very little volatility. Reconciled Depreciation is likely to outpace its year average in 2025. From the period from 2010 to 2025, Tarsus Pharmaceuticals Reconciled Depreciation quarterly data regression had r-value of  0.79 and coefficient of variation of  167.34. View All Fundamentals
 
Reconciled Depreciation  
First Reported
2017-12-31
Previous Quarter
239 K
Current Value
284 K
Quarterly Volatility
99.3 K
 
Covid
Check Tarsus Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tarsus Pharmaceuticals' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 7.5 M or Depreciation And Amortization of 529.3 K, as well as many indicators such as Price To Sales Ratio of 13.51, Dividend Yield of 0.0 or PTB Ratio of 9.74. Tarsus financial statements analysis is a perfect complement when working with Tarsus Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Tarsus Pharmaceuticals Correlation against competitors.
For more information on how to buy Tarsus Stock please use our How to Invest in Tarsus Pharmaceuticals guide.

Latest Tarsus Pharmaceuticals' Reconciled Depreciation Growth Pattern

Below is the plot of the Reconciled Depreciation of Tarsus Pharmaceuticals over the last few years. It is Tarsus Pharmaceuticals' Reconciled Depreciation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tarsus Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Reconciled Depreciation10 Years Trend
Slightly volatile
   Reconciled Depreciation   
74.0246.312.325.628.1.2M1.3M232%27%4%93%95%5%100%
       Timeline  

Tarsus Reconciled Depreciation Regression Statistics

Arithmetic Mean256,578
Geometric Mean13,847
Coefficient Of Variation167.34
Mean Deviation311,670
Median1,000.00
Standard Deviation429,348
Sample Variance184.3B
Range1.3M
R-Value0.79
Mean Square Error73.3B
R-Squared0.63
Significance0.0002
Slope71,507
Total Sum of Squares2.8T

Tarsus Reconciled Depreciation History

20251.3 M
20241.2 M
2023628 K
2022325 K
2021312 K
2020246 K
201974 K

About Tarsus Pharmaceuticals Financial Statements

Tarsus Pharmaceuticals shareholders use historical fundamental indicators, such as Reconciled Depreciation, to determine how well the company is positioned to perform in the future. Although Tarsus Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Tarsus Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Tarsus Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Reconciled Depreciation1.2 M1.3 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Tarsus Stock Analysis

When running Tarsus Pharmaceuticals' price analysis, check to measure Tarsus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tarsus Pharmaceuticals is operating at the current time. Most of Tarsus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tarsus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tarsus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tarsus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.